Search research articles
Contact Us
Filters
Showing results (1-10 of 103) with videos related to
Page
of 11
Sort By:
Rivista Italiana Di Ginecologia
|
November 1, 1974
[Value of clotrimazole (BAY B 5097 or Canesten) as an antimycotic, antiprotozoal and antibacterial agent in vulvo-vaginal inflammations]
V Facchini
Xenobiotica; the Fate of Foreign Compounds in Biological Systems
|
April 1, 1980
The metabolic fate of nitromide in the rat. I. Metabolism and excretion
V Facchini, L A Griffiths
Xenobiotica; the Fate of Foreign Compounds in Biological Systems
|
April 1, 1980
Metabolism of nitromide in the rat. II. Sites of nitro-reduction
V Facchini, L A Griffiths
Journal of Chromatography
|
August 8, 1980
Determination of hydralazine metabolites: 4-hydrazino-phthalazin-1-one and n-acetylhydrazinophthalazin-1-one by gas chromatography and s-triazolo[3,4-alpha]phthalazine and phthalazinone by high-performance liquid chromatography
V Facchini, J A Timbrell
British Journal of Clinical Pharmacology
|
April 1, 1981
Further evidence for an acetylator phenotype difference in the metabolism of hydralazine in man
V Facchini, J A Timbrell
Biochemical Pharmacology
|
May 1, 1981
The involvement of the gastro-intestinal microflora in nitro-compound-induced methaemoglobinaemia in rats and its relationship to nitrogroup reduction
V Facchini, L A Griffiths
Drug Metabolism and Drug Interactions
|
January 1, 1989
Metabolism and disposition studies with a [35S]-labelled growth promotor: bis(N1-methyl-N2-methylsulphonyl) guanidinylethyl] disulphide
V Facchini, M Jones, G E Smith
Annali Di Ostetricia, Ginecologia, Medicina Perinatale
|
May 1, 1988
[Serum CA 125 and TPA determination in malignant neoplasms of the uterus]
A Gadducci, V Facchini, T Bartolini, et al.
Clinical Pharmacology and Therapeutics
|
September 1, 1980
Polymorphic acetylation of hydralazine
J A Timbrell, S J Harland, V Facchini
Clinical and Experimental Obstetrics & Gynecology
|
January 1, 1994
Percutaneous nephrostomy in patients with advanced or recurrent cervical cancer
A Gadducci, A Madrigali, V Facchini, et al.
Page
of 11
Search research articles
Search
Showing results (1-10 of 103) with videos related to
Sort By:
Page
of 11
Rivista Italiana Di Ginecologia
|
November 1, 1974
[Value of clotrimazole (BAY B 5097 or Canesten) as an antimycotic, antiprotozoal and antibacterial agent in vulvo-vaginal inflammations]
V Facchini
Xenobiotica; the Fate of Foreign Compounds in Biological Systems
|
April 1, 1980
The metabolic fate of nitromide in the rat. I. Metabolism and excretion
V Facchini, L A Griffiths
Xenobiotica; the Fate of Foreign Compounds in Biological Systems
|
April 1, 1980
Metabolism of nitromide in the rat. II. Sites of nitro-reduction
V Facchini, L A Griffiths
Journal of Chromatography
|
August 8, 1980
Determination of hydralazine metabolites: 4-hydrazino-phthalazin-1-one and n-acetylhydrazinophthalazin-1-one by gas chromatography and s-triazolo[3,4-alpha]phthalazine and phthalazinone by high-performance liquid chromatography
V Facchini, J A Timbrell
British Journal of Clinical Pharmacology
|
April 1, 1981
Further evidence for an acetylator phenotype difference in the metabolism of hydralazine in man
V Facchini, J A Timbrell
Biochemical Pharmacology
|
May 1, 1981
The involvement of the gastro-intestinal microflora in nitro-compound-induced methaemoglobinaemia in rats and its relationship to nitrogroup reduction
V Facchini, L A Griffiths
Drug Metabolism and Drug Interactions
|
January 1, 1989
Metabolism and disposition studies with a [35S]-labelled growth promotor: bis(N1-methyl-N2-methylsulphonyl) guanidinylethyl] disulphide
V Facchini, M Jones, G E Smith
Annali Di Ostetricia, Ginecologia, Medicina Perinatale
|
May 1, 1988
[Serum CA 125 and TPA determination in malignant neoplasms of the uterus]
A Gadducci, V Facchini, T Bartolini, et al.
Clinical Pharmacology and Therapeutics
|
September 1, 1980
Polymorphic acetylation of hydralazine
J A Timbrell, S J Harland, V Facchini
Clinical and Experimental Obstetrics & Gynecology
|
January 1, 1994
Percutaneous nephrostomy in patients with advanced or recurrent cervical cancer
A Gadducci, A Madrigali, V Facchini, et al.
Page
of 11